1. Cyclooxygenase-1 deficiency in bone marrow cells increases early atherosclerosis in apolipoprotein E- and low-density lipoprotein receptor-null mice. Babaev VR, Ding L, Reese J, Morrow JD, Breyer MD, Dey SK, Fazio S, Linton MF (2006) Circulation 113(1): 108-17
    › Primary publication · 16380543 (PubMed)
  2. Antiatherogenic effects of angiotensin receptor antagonism in mild renal dysfunction. Suganuma E, Zuo Y, Ayabe N, Ma J, Babaev VR, Linton MF, Fazio S, Ichikawa I, Fogo AB, Kon V (2006) J Am Soc Nephrol 17(2): 433-41
    › Primary publication · 16371432 (PubMed)
  3. ACAT1 deficiency increases cholesterol synthesis in mouse peritoneal macrophages. Dove DE, Su YR, Swift LL, Linton MF, Fazio S (2006) Atherosclerosis 186(2): 267-74
    › Primary publication · 16144700 (PubMed)
  4. The recycling of apolipoprotein E in macrophages: influence of HDL and apolipoprotein A-I. Hasty AH, Plummer MR, Weisgraber KH, Linton MF, Fazio S, Swift LL (2005) J Lipid Res 46(7): 1433-9
    › Primary publication · 15805547 (PubMed)
  5. Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null mice. Liu J, Thewke DP, Su YR, Linton MF, Fazio S, Sinensky MS (2005) Arterioscler Thromb Vasc Biol 25(1): 174-9
    › Primary publication · 15499039 (PubMed) · PMC2649706 (PubMed Central)
  6. Reduced ABCA1-mediated cholesterol efflux and accelerated atherosclerosis in apolipoprotein E-deficient mice lacking macrophage-derived ACAT1. Su YR, Dove DE, Major AS, Hasty AH, Boone B, Linton MF, Fazio S (2005) Circulation 111(18): 2373-81
    › Primary publication · 15851589 (PubMed)
  7. Physiological relevance of apolipoprotein E recycling: studies in primary mouse hepatocytes. Zhu MY, Hasty AH, Harris C, Linton MF, Fazio S, Swift LL (2005) Metabolism 54(10): 1309-15
    › Primary publication · 16154429 (PubMed)
  8. Persistence of high density lipoprotein particles in obese mice lacking apolipoprotein A-I. Gruen ML, Plummer MR, Zhang W, Posey KA, Linton MF, Fazio S, Hasty AH (2005) J Lipid Res 46(9): 2007-14
    › Primary publication · 15995171 (PubMed)
  9. Interplay between apolipoprotein E and scavenger receptor class B type I controls coronary atherosclerosis and lifespan in the mouse. Fazio S, Linton MF (2005) Circulation 111(25): 3349-51
    › Primary publication · 15983260 (PubMed)
  10. Inhibition of cyclooxygenase with indomethacin phenethylamide reduces atherosclerosis in apoE-null mice. Burleigh ME, Babaev VR, Patel MB, Crews BC, Remmel RP, Morrow JD, Oates JA, Marnett LJ, Fazio S, Linton MF (2005) Biochem Pharmacol 70(3): 334-42
    › Primary publication · 15950196 (PubMed)